MBOT | Microbot Medical Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.4350 - 1.5400
52 Week Range	0.8200 - 3.38
Beta	1.54
Implied Volatility	240.11%
IV Rank	72.45%
Day's Volume	465,624
Average Volume	4,251,256
Shares Outstanding	34,744,500
Market Cap	50,032,080
Sector	Healthcare
Industry	Medical - Instruments & Supplies
IPO Date	1992-03-25

Valuation
Profitability
Growth
Health
P/E Ratio	-1.82
Forward P/E Ratio	N/A
EPS	-0.79
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	21
Country	USA
Website	MBOT

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

MBOT's peers: GCTK, BNGO, SDC, ISRG, INND, POAI, STAA, BDX, WST, RMD, GMVD, STSS, ZJYL, MHUA, LUCY

*Chart delayed

Analyzing fundamentals for MBOT we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see MBOT Fundamentals page.

Watching at MBOT technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on MBOT Technicals page.